新たな研究がアルツハイマー病の血液検査に警鐘を鳴らす(New Study Raises Alarm Over Alzheimer’s Blood Tests)

ad

2025-02-24 ラトガース大学

ラトガース大学の研究者たちは、アルツハイマー病の診断に用いられる血液検査の信頼性に関する懸念を提起しました。彼らの研究によれば、血液中のバイオマーカー、特にアミロイドβやタウタンパク質の測定結果が、患者の年齢、遺伝的背景、併存疾患などの要因によって影響を受ける可能性があることが示されています。これにより、誤診や過剰診断のリスクが高まる可能性があり、研究者たちは、血液検査の結果を解釈する際には、これらの要因を慎重に考慮する必要があると指摘しています。

<関連情報>

2つの多様なコホートにおける認知障害と人種が血漿p-Tau217に及ぼす影響 Influence of cognitive impairment and race on plasma p-Tau217 in two diverse cohorts

Ashima NayyarMei-ling LiVictor SoteloGuibin SuIsabelle HwangMilota KaluzovaMini JomartinMichelle MigutHilary Grosso JasutkarKarlyndsay SitterleyKarthik J. KotaWilliam T. Hu
Alzheimer’s & Dementia  Published: 23 February 2025
DOI:https://doi.org/10.1002/alz.14585

新たな研究がアルツハイマー病の血液検査に警鐘を鳴らす(New Study Raises Alarm Over Alzheimer’s Blood Tests)

Abstract

INTRODUCTION
Factors influencing plasma Alzheimer’s disease (AD) biomarkers remain incompletely understood. Here we evaluated Fujirebio plasma p-Tau217 in two diverse cohorts among whom 91% underwent cerebrospinal fluid (CSF) analysis.

METHODS
Non-Hispanic White (NHW, n = 113), Black/African American (B/AA, n = 66), and Chinese American (ChA, n = 38) participants recruited from two universities were included. We examined if plasma p-Tau217 correlated with CSF and clinical factors, differed between racial groups, and associated with novel CSF proteins.

RESULTS
CSF p-Tau181 strongly correlated with CSF p-Tau217 (R2 = 0.912) which moderately correlated with plasma p-Tau217 (R2 = 0.694). Plasma p-Tau217 levels were higher with greater cognitive impairment but lower in B/AA than NHW participants even after adjusting for CSF p-Tau181. This resulted in greater positive predictive value for NHW than B/AA participants, and could be mediated by complement or lysosomal pathways.

DISCUSSION
Severity of cognitive impairment and race both influence plasma p-Tau217 levels beyond race-associated differences in CSF p-Tau181.

Highlights

  • Cognitive impairment associates with plasma p-Tau217 independent of CSF biomarkers.
  • Black/African Americans had lower plasma p-Tau217 than non-Hispanic White Americans.
  • CSF p-Tau181 could not explain lower plasma p-Tau217 in Black/African Americans.
  • Plasma p-Tau217 difference results in more false positive cases according to race.
  • Novel CSF processes were associated with race-related plasma p-Tau217 difference.
医療・健康
ad
ad
Follow
ad
タイトルとURLをコピーしました